Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Corrigendum.
Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction.
Natalizumab therapy for multiple sclerosis.
A Case Report of Obsessive-Compulsive Disorder Following Acute Disseminated Encephalomyelitis.
Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.
Subcutaneous IgG in neurologic diseases.
Multiple sclerosis: Cognitive training provides lasting benefits for patients with multiple sclerosis.
Cerebrospinal fluid oligoclonal IgG bands in multiple sclerosis: what does it mean?
Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Gilenya Safety Update
Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease.
Acid-sensing ion channels in pathological conditions.
[Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
LC-MS/MS identification of the one-carbon cycle metabolites in human plasma.
Elevated Cerebrospinal Fluid Opening Pressure in a Pediatric Demyelinating Disease Cohort.
Functional brain imaging: an evidence-based analysis.
PEGylated IFNβ-1a in the treatment of multiple sclerosis.
Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability.
Stem cells in neurology - current perspectives.
Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?
[Chronic cough and worsening dyspnea: a case of idiopathic tracheal stenosis].
Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline.
Gender and autoimmune comorbidity in multiple sclerosis.
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.
Pages
« first
‹ previous
…
363
364
365
366
367
368
369
370
371
…
next ›
last »
